Affected individuals have a high level of an antibody called immunoglobulin m igm in their blood, which can cause thickening of the blood hyperviscosity. It usually affects older adults and is primarily found in the bone marrow, although lymph nodes and the spleen may be involved. Waldenstrom macroglobulinemia patient symposium proposed speaker coordinator. It occurs in a type of white blood cell called a blymphocyte or bcell.
The median age of wm patients at presentation is 63 to 68 years, with men comprising 5570% of cases. Most people with wm are treated for some time, followed by a break, and then treated again when the disease comes back. New recommendations are given regarding the role of myd88 l265p detection in the diagnosis of wm and the role of ibrutinib in the treatment of symptomatic wm. Current treatments for waldenstrom macroglobulinemia wm are not likely to result in a cure.
Waldenstrom macroglobulinemia is a chronic, slowgrowing lymphoproliferative disorder. The following sources were used in preparing our information about waldenstrom macroglobulinemia. Waldenstrom macroglobulinemia what cancer patients, their families, and caregivers need to know about covid19. Neuropathy is a process in which multiple nerves become diseased or damaged there are many causes for neuropathy the immune system plays a role, specifically in producing too much of a certain type of protein monoclonal gammopathy 3050% of individuals with waldenstroms macroglobulinemia develop neuropathy most of these individuals have a. Whether you or someone you love has cancer, knowing what to expect can help you cope. Asking the right questions during conversations with your doctor will help you know what to expect and how to better navigate thiscondition. Exciting clinical trials with oral agents are ongoing. Pronunciation of waldenstrom macroglobulinemia with 1 audio pronunciation, 1 meaning, 8 translations and more for waldenstrom macroglobulinemia. Frequently asked questions international waldenstroms. Further studies are needed to establish its efficacy against current standard treatments and to investigate whether outcomes can be improved with combination therapies.
More detailed information about the specific medications used to treat waldenstrom macroglobulinemia can be viewed on medscape references web site. Waldenstrom macroglobulinemia remains a rare, incurable cancer, with a heterogeneous disease course. Waldenstrom macroglobulinemia wm, an igmassociated lymphoplasmacytic lymphoma, has. This condition is classified as a lymphoplasmacytic lymphoma.
Wm is also referred to as a bcell lymphoproliferative disease, and it accounts for approximately 1 to 2 percent of hematologic blood cancers. From basic information about cancer and its causes to indepth information on specific cancer types including risk factors, early detection, diagnosis, and treatment options youll find it here. Waldenstrom macroglobulinemia wm is a bcell malignancy that accounts for 12% of hematologic malignancies, with an estimated 1,500 new cases annually in the u. The international prognostic scoring system for waldenstrom s macroglobulinemia is applicable in patients treated with rituximabbased regimens.
Waldenstrom s macroglobulinemia bcell proliferative disorder with bone marrow lymphoplasmacytic infiltration and production of monoclonal igm. Waldenstrom macroglobulinemia wm is an uncommon bcell cancer that is classified by the world health organization as a subtype of nhl. Waldenstrom macroglobulin country includes continents region includes us states, etc. Diagnosis and management of waldenstrom macroglobulinemia. Though ibrutinib has proven to be a revolutionary new small molecule agent, and has relatively minimal toxicity as compared to traditional chemotherapy, infections have. Learning to live with cancer that does not go away can be difficult and very stressful. This fact sheet provides specific information about the. There is support out there for people living with andor affected by waldenstrom macroglobulinemia wm. Wm is considered to be an indolent slow growing lymphoma that usually affects older adults and is primarily found in the bone marrow although lymph nodes and spleen may also be involved. Waldenstrom macroglobulinemia wm is rare, with an incidence rate of about 3 cases per million people per year in the united states. Steve kirschs waldenstrom s macroglobulinemia links.
It occurs in a type of white blood cell called a blymphocyte or bcell, which normally matures into a plasma cell that manufactures immunoglobulins also called antibodies to help the body fight infection. This condition is considered to be lymphoplasmacytic lymphoma as defined by the real and who classification systems 2, 3. Thankfully, according to patient worthy partner international waldenstrom s macroglobulinemia foundation iwmf, a gap may be bridged between individuals and support groups. Some affected individuals have elevated levels of igm and lymphoplasmacytic cells but no symptoms of the condition. Carfilzomib, rituximab, and dexamethasone card treatment. Waldenstrom macroglobulinemia is a rare lymphoproliferative disorder with distinctive clinical features. Generating an epub file may take a long time, please be patient. Wm is characterized by having high levels of a circulating antibody, immunoglobulin m igm, which is made and secreted by the cells involved in the disease. Waldenstrom macroglobulinemia usually begins in a persons sixties and is a slowgrowing indolent cancer. Lenalidomide and rituximab in waldenstroms macroglobulinemia. Carfilzomib is a neuropathysparing proteasome inhibitor. Waldenstroms macroglobulinemia wm is a lymphoma, or cancer of the lymphatic system. The ocular complications in this disease are being reported with increasing frequency with the spectrum of retinal changes ranging. Treatment choice in waldenstrom disease is strictly guided by patients age and characteristics, specific goals of therapy, the necessity for rapid.
Nephrotic syndrome and kidney failure due to immunocomplex. Macroglobulinemia is a disease of the reticuloendothelial system in which the signs and symptoms are associated with an abnormal protein having a high molecular weight. It usually affects older adults and is primarily found in the bone. Future treatments are likely to be less toxic and more effective. Help worldwide based on 921 articles published since 2007 in each column, black bars show the relative amount of expertise for each place or person. Hsv1 encephalitis in an elderly man receiving ibrutinib. Bing center for waldenstrom s macroglobulinemia, dana farber cancer institute, and department of medicine, harvard medical school, boston, ma. Waldenstrom s macroglobulinemia wm is a bcell disorder characterized primarily by bone marrow infiltration with lymphoplasmacytic cells along with demonstration of an igm monoclonal gammopathy.
Wm is more common in men than it is in women, and it is much more common among whites than african americans. Kyle monoclonal gammopathy of undetermined significance shaji kumar, m. Symptoms and complications are related to tumor burden or quantity or to the physicochemical or immunological. The diagnosis of wm is established by the presence of lymphoplasmacytic lymphoma in the bone marrow or other organs, a.
Waldenstrom macroglobulinemia genetics home reference nih. Neuropathy is a process in which multiple nerves become diseased or damaged there are many causes for neuropathy the immune system plays a role, specifically in producing too much of a certain type of protein monoclonal gammopathy 3050% of individuals with waldenstroms macroglobulinemia develop neuropathy most of these individuals have a demyelinating neuropathy which is mild. About 1,000 to 1,500 people are diagnosed with wm each year in the united states. Ibrutinib is a major new addition to the therapeutic armamentarium for chronic lymphocytic leukemia, mantle cell lymphoma, waldenstrom s macroglobulinemia, and chronic graft versus host disease. Lymphoma is the name for many different types of cancer that arise in the lymphocytes white blood cells. Waldenstrom macroglobulinemia genetic and rare diseases.
Bendamustine, bortezomib, carfilzomib and cyclophosphamide are highly effective when combined with rituximab. What is new in the treatment of waldenstrom macroglobulinemia. Pdf waldenstroms macroglobul inemia is an uncommon lymphoplasmacytic lymphoma presenting with hyperviscocity and autoimmune phenomenon. Iwmf support groups can render support for patients, their family. Radiation oncologywaldenstroms wikibooks, open books. Waldenstroms macroglobulinemia wm is a clonal bcell lymphoproliferative disorder characterized primarily by bone marrow infiltration. Fill out the questionnaire online, save to a file, and email the file to. If you have problems viewing pdf files, download the latest version of adobe reader. The abnormal cells have characteristics of both white blood cells lymphocytes called b cells and of more mature cells derived from b cells. How to say waldenstrom macroglobulinemia in english.
181 692 819 695 1015 1189 1563 354 676 686 1420 1335 372 865 1142 410 281 293 976 1011 129 1468 1405 1097 961 1472 474 881 103 1276 985 151 1375 526 654 1361 144 1144 1461 1066